Merck Loses Fosamax Trial, Resulting in $285,000 Verdict
In a court room upset, Merck & Co. Inc. lost its second Fosamax lawsuit to a New York resident who claimed she suffered jaw injury due to the side effects of the osteoporosis drug. Reuters reports that the jury awarded the plaintiff $285,000 in the case, which was originally... READ MORE